You are here

Pradaxa

Doctors say blood-clot drug race too close to call

Reuters

Tue, 11/16/10 - 11:59 am

Boehringer Ingelheim

A Mega-Blockbuster Showdown

Motley Fool

Mon, 11/15/10 - 06:28 pm

Boehringer Ingelheim

Boehringer Drug Lowers Bleeding Risk in Those Who Had Stroke

Bloomberg

Mon, 11/8/10 - 10:43 am

Boehringer Ingelheim

Bayer rival Boehringer prices blood pill at $6.75

Reuters

Tue, 10/26/10 - 11:52 am

Boehringer Ingelheim

Boehringer Wins FDA Approval for First Warfarin Rival

Bloomberg

Tue, 10/19/10 - 06:46 pm

Boehringer Ingelheim

FDA's Top Q4 Blockbuster Drug Decisions

Fierce Biotech

Tue, 10/12/10 - 11:26 am

U.S. panel backs Boehringer drug to reduce strokes

Reuters

Tue, 09/21/10 - 09:20 am

advisory panels

Boehringer Ingelheim

Bayer Chief Envisions $15 Billion Market for Xarelto, New Blood Thinners

Bloomberg

Thu, 09/16/10 - 12:29 pm

Boehringer Ingelheim

Bristol-Myers Squibb

Pfizer, Bayer, Boehringer Bid to Replace Warfarin in Stroke-Drug Market

Bloomberg

Mon, 08/30/10 - 10:39 am

Boehringer Ingelheim

FDA panel to vet Boehringer blood thinner Sept 20

Reuters

Fri, 08/27/10 - 10:19 am

advisory panels

Boehringer Ingelheim

Boehringer’s Pradaxa Matches Warfarin as Clot Therapy in Study

Bloomberg

Mon, 11/23/09 - 09:03 am

Boehringer Ingelheim

Boehringer Ingelheim likely to have regulatory submission for Pradaxa delayed

FT.com

Thu, 09/10/09 - 11:27 am

Boehringer Ingelheim

Regulatory questions for Astra, Boehringer drugs

Reuters

Mon, 08/31/09 - 07:44 am

Boehringer Ingelheim

Pages